c-kit-Immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions
Open Access
- 1 August 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (2) , H518-H524
- https://doi.org/10.1152/ajpheart.00002.2004
Abstract
Progress in the treatment of human in-stent restenosis (ISR) is hampered by an imprecise understanding of the nature of the cells that occlude vascular stents. Recent studies suggest that circulating vascular progenitor cells may mediate vascular repair and lesion formation. Moreover, functional endothelial progenitor cells appear to play a protective role in attenuating vascular lesion formation. Hence, we sought to answer two important questions: 1 ) Are primitive cells found in ISR lesions? 2 ) Is the abundance of cultured angiogenic cells (CACs) in patients with ISR different from that in patients with non-ISR lesions or normal controls? Human coronary atherectomy tissue from 13 ISR, 6 postangioplasty restenosis (RS), and 14 primary (PR) atherosclerotic lesions, as well as 15 postmortem coronary artery cross sections from young individuals without atherosclerosis, were studied. All 13 ISR and 4 of 6 RS tissue specimens contained cells that immunolabeled for the primitive cell marker c-kit and smooth muscle α-actin, whereas the intima and media of PR lesions and normal arteries were devoid of c-kit-immunopositive cells. The abundance of peripheral blood mononuclear cell-derived CACs was assessed in 10 patients with ISR, 6 patients with angiographically verified patent stents, and 6 individuals with no clinical evidence of coronary artery disease. CACs were less abundant in ISR patients than in non-ISR controls (13.9 ± 3.1 vs. 22.3 ± 6.7 cells/high-power field, P < 0.05), and both of these groups had fewer CACs than non-coronary artery disease patients (37.6 ± 3.8, P < 0.05). These findings suggest a unique pathogenesis for ISR and RS lesions that involves c-kit-immunopositive smooth muscle cells. Moreover, the paucity of CACs in patients with ISR may contribute to the pathogenesis of ISR, perhaps because of attenuated reendothelialization.Keywords
This publication has 30 references indexed in Scilit:
- Antagonism of the α4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formationJournal of Leukocyte Biology, 2004
- Number and Adhesive Properties of Circulating Endothelial Progenitor Cells in Patients With In-Stent RestenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Aging, Progenitor Cell Exhaustion, and AtherosclerosisCirculation, 2003
- Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular InjuryCirculation Research, 2003
- Endothelial Progenitor Cells Isolation and CharacterizationTrends in Cardiovascular Medicine, 2003
- Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activityCanadian Journal of Physiology and Pharmacology, 2003
- Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth FactorsCirculation, 2003
- Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferationAmerican Heart Journal, 2002
- Statin Therapy Accelerates ReendothelializationCirculation, 2002
- Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissuesImmunology & Cell Biology, 1987